700 A phase II trial of MOnaliZumab plus durvAlumab plus platinum-based chemotheRapy for first-line treatment of extensive stage small cell lung cancer (MOZART): A Hoosier Cancer Research Network study
Main Authors: | Seongho Kim, Jie Chi, Hirva Mamdani, Shadia I Jalal, Kristen Pizana, Qura Abid |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors
by: Jarushka Naidoo, et al.
Published: (2024-02-01) -
Cracker and Hoosier
by: Raven I. Mcdavid Jr., et al.
Published: (1973-09-01) -
A converse to the jordan curve theorem for digital durves/
by: Rosenfeld, Azriel -
Understanding St. Louis’ Love for Hoosier
by: Daniel Duncan
Published: (2018-01-01) -
Monalizumab: inhibiting the novel immune checkpoint NKG2A
by: Thorbald van Hall, et al.
Published: (2019-10-01)